Page last updated: 2024-08-23

phosphotyrosine and Placenta Increta

phosphotyrosine has been researched along with Placenta Increta in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahtiyar, MO; Buhimschi, CS; Buhimschi, IA; Campbell, KH; Funai, EF; Laky, C; Salafia, C; Sfakianaki, AK; Thung, S; Wehrum, MJ; Werner, EF; Zhao, G	1

Other Studies

1 other study(ies) available for phosphotyrosine and Placenta Increta

Article	Year
Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:5 Topics: Adult; Case-Control Studies; Epithelial-Mesenchymal Transition; Female; Humans; Keratin-7; Phosphotyrosine; Placenta Accreta; Placenta Growth Factor; Placenta Previa; Pregnancy; Pregnancy Proteins; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vimentin	2011

Article

Year

Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.

American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:5

Topics: Adult; Case-Control Studies; Epithelial-Mesenchymal Transition; Female; Humans; Keratin-7; Phosphotyrosine; Placenta Accreta; Placenta Growth Factor; Placenta Previa; Pregnancy; Pregnancy Proteins; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vimentin

2011